Search Results
Jun 19, 2026, 08:08 ET Na targach Hong Kong Expo 2026 Geely Farizon prezentuje ekologiczny i inteligentny ekosystem mobilności
Oferta Geely Farizon obejmuje następujące modele: zasilany metanolem REV SV, zasilany metanolem REV Homtruck, zasilany metanolem lekki pojazd dostawczy REV Light Truck, autonomiczna taksówka Robotaxi, zasilany metanolem REV U12M, zaprojektowane specjalnie dla Hongkongu elektryczne autobusy piętrowe,
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 19, 2026, 08:07 ET Die „Geely Farizon Green Smart Mobility Solution" feiert auf der Hong Kong Expo 2026 ihr Debüt
Das Produktportfolio von Farizon umfasst die Methanol-REV-Modelle SV, Homtruck, Leicht-Lkw und U12M, ein Robotaxi, speziell auf Hongkong zugeschnittene elektrische Doppeldeckerbusse sowie mobile Stromversorgungsfahrzeuge
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 19, 2026, 07:18 ET Geely Farizon Luncurkan Solusi Mobilitas Hijau dan Cerdas di Hong Kong Expo 2026
Jajaran produk tersebut antara lain REV SV metanol, REV Homtruck metanol, truk kecil metanol REV, Robotaxi, REV U12M metanol, bus listrik tingkat dua yang dirancang khusus untuk Hong Kong, kendaraan penyedia listrik bergerak
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 19, 2026, 07:17 ET Geely Farizon giới thiệu giải pháp giao thông xanh thông minh tại Triển lãm Hồng Kông 2026
Danh mục sản phẩm của Farizon bao gồm SV sử dụng công nghệ methanol REV, Homtruck methanol REV, xe tải nhẹ methanol REV, Robotaxi, U12M methanol REV, xe buýt điện hai tầng thiết kế riêng cho Hong Kong, cùng các xe cung cấp nguồn điện lưu động Visionol, máy phát
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 19, 2026, 02:15 ET La solución de movilidad inteligente y ecológica Geely Farizon debuta en la Expo de Hong Kong 2026
La gama de Farizon incluye el REV SV de metanol, el camión REV Homtruck de metanol, el camión ligero REV de metanol, el Robotaxi, el REV U12M de metanol, autobuses eléctricos de dos pisos adaptados a Hong Kong, además de vehículos de
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 18, 2026, 11:19 ET Geely Farizon Green Smart Mobility Solution Debuts at 2026 Hong Kong Expo
Farizon's lineup covers methanol REV SV, methanol REV Homtruck, methanol REV light truck, Robotaxi, methanol REV U12M, Hong Kong-tailored electric double-deckers, plus Visionol mobile power vehicles, methanol generators and
More news about: Geely Farizon New Energy Commercial Vehicle Group
Jun 18, 2026, 08:05 ET The NHP Foundation and Trinity East Village CDC Close Financing on Trinity East Village Senior, Helping Third Ward Seniors Age in Place
community-driven planning and partnership aimed at ensuring that longtime Third Ward residents are not left behind as the neighborhood evolves," said Rev. Dr. Marilyn White, Executive Director of Trinity East Village CDC. "It is so rewarding to partner with an organization that shares our vision for a
More news about: NHP Foundation
Jun 17, 2026, 14:27 ET The Church of Jesus Christ Joins with Faith and Community Leaders to Feed Families in All 50 States for America250
bank.According to Forgotten Harvest, food demand has increased between 15% to 30%."This is more than a distribution. This is a lifeline," said the Rev. Yvette Griffin of Pilgrim Baptist Church in Detroit.Across the country, these efforts are often carried out through collaborations among faith
More news about: The Church of Jesus Christ of Latter-day Saints
Jun 16, 2026, 16:05 ET Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
comparison with the general population. Sleep Med. 2013;14(6):488-492. Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev. 2016;29:23-33. Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12(3):331-344. American Academy of Sleep Medicine. The
More news about: Jazz Pharmaceuticals plc
Jun 15, 2026, 06:00 ET King's College and eCampus.com Expand Partnership with Launch of Equitable Access Program
opportunities to enhance the student experience while remaining faithful to our mission of making a high-quality education accessible and transformative," said Rev. Thomas P. Looney, C.S.C., Ph.D., president of King's College. "eCampus.com has been a trusted partner for several years, and the launch of Monarch Access
More news about: eCampus.com
Jun 09, 2026, 08:05 ET Magna5 Warns Defense Contractors: CMMC Is a Business Requirement, Not an IT Checklist
Standards and Technology. (2021). Protecting Controlled Unclassified Information in nonfederal systems and organizations (Special Publication 800-171 Rev. 2). csrc.nist.gov/pubs/sp/800/171/r2/upd1/finalOffice of the Secretary, Department of Defense. (2024, October 15). Cybersecurity Maturity
More news about: Magna5
Jun 08, 2026, 16:00 ET ACE Commission on Faith-Based Colleges and Universities Convenes National Leaders to Model Civil Dialogue on Campuses
President Linda A. Livingstone of Baylor University, President C. Shane Reese of Brigham Young University, Rabbi Dr. Ari Berman of Yeshiva University, and Rev. Robert A. Dowd of the University of Notre Dame."Engaging across differences is more important than ever and faith-based colleges and universities
More news about: American Council on Education
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
American Diabetes Association Scientific Sessions; June 5-8, 2026, New Orleans, LA.Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Pharmacol Rev. 2015;67(3):564–600. doi: 10.1124/pr.115.010629Muhammad T, Pastore SF, Good K, Yu WH, Vincent JB.. FASEB Bioadv. 2025;7(3):e1480. doi:
More news about: NOVO NORDISK INC.
Jun 07, 2026, 14:30 ET 頭對頭：埃諾格魯肽體重降幅顯著優於司美格魯肽35%
12-B. Study number SCW0502-11222 Ji L, et al. Lancet Diabetes Endocrinol. 2025 Sep;13(9):777-7893 Mullard A. Nat Rev Drug Discov. 2023 May;22(5)347-348.
More news about: 杭州先為達生物科技股份有限公司
Jun 07, 2026, 14:30 ET Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
2026 ADA poster 12-B. Study number SCW0502-1122Ji L, et al. Lancet Diabetes Endocrinol. 2025 Sep;13(9):777-789Mullard A. Nat Rev Drug Discov. 2023 May;22(5)347-348.
More news about: Sciwind Biosciences Co., Ltd.
Jun 06, 2026, 13:00 ET Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.
Jun 05, 2026, 10:00 ET Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
Nguyen MA, et al. Pathology. 2023 Aug;55(5):596-609.Jiang T, et al. Acta Pharm Sin B. 2021 Feb;11(2):355-372.Cocco E, et al. Nat Rev Clin Oncol. 2018 Dec;15(12):731-747.O'Haire S, et al. Sci Rep. 2023 Mar 13;13(1):4116.Qi C, et al. Int J Cancer. 2023 Dec 1;153(11):1916-1927.Vcare
More news about: Vcare PharmaTech
Jun 04, 2026, 16:45 ET Mammotome erweitert den Zugang zu einem innovativen Marker für Brustbiopsie-Entnahmestellen
www.danaher.com.1. HydroMARK™ Plus Gerätetest - PCR-000299, SDR0098 Vakuum-Saugprüfung2. HydroMARK™ Konstruktionsplan - ADD-00013 Rev G, Seite 193. HydroMARK™ Gerätetest - PCR-000414, Summative Benutzerfreundlichkeit4. Sakamoto N, Fukuma E, Tsunoda Y, Teraoka K, Koshida
More news about: MAMMOTOME
Jun 04, 2026, 16:41 ET Mammotome amplía el acceso a un innovador marcador para la biopsia de mama
www.danaher.com.1. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing2. HydroMARK™ Design Plan - ADD-00013 Rev G, Page 193. HydroMARK™ Device Test - PCR-000414, Summative Usability4. Sakamoto N, Fukuma E, Tsunoda Y, Teraoka K, Koshida Y. Evaluation
More news about: MAMMOTOME
Jun 04, 2026, 16:36 ET Mammotome élargit l'accès à un marqueur innovant de site de biopsie mammaire
www.danaher.com.1. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing2. HydroMARK™ Design Plan - ADD-00013 Rev G, Page 193. Test de l'appareil HydroMARK™ - PCR-000414, Summative Usability4. Sakamoto N, Fukuma E, Tsunoda Y, Teraoka K, Koshida Y. « Evaluation
More news about: MAMMOTOME
Jun 04, 2026, 15:34 ET Greater Miami Convention & Visitors Bureau reports strong tourism performance, positioning Miami-Dade County for continued growth
Miami Spice and the South Beach Wine & Food Festival to marquee events including FIFA World Cup 26 ™.Tourism's engine in 2025 helped rev up Miami-Dade County's economy, driving consumer spending, supporting local businesses and sustaining thousands of jobs across the region. Visitors spent
More news about: Greater Miami Convention & Visitors Bureau
Jun 04, 2026, 08:15 ET Clinicians to Share Practical Strategies for Point-of-Care Ultrasound Probe Disinfection at APIC26
headquartered near Cambridge, United Kingdom, operates globally, and is listed on the London Stock Exchange's AIM market (AIM: TSTL).MKT-45-0073 Rev OLiz Dowling | 760-822-3412 | [email protected] Halasey
More news about: Parker Laboratories
Jun 04, 2026, 04:00 ET Mammotome Expands Access to Innovative Breast Biopsy Site Marker
www.danaher.com.1. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing2. HydroMARK™ Design Plan - ADD-00013 Rev G, Page 193. HydroMARK™ Device Test - PCR-000414, Summative Usability4. Sakamoto N, Fukuma E, Tsunoda Y, Teraoka K, Koshida Y. Evaluation
More news about: MAMMOTOME
Jun 03, 2026, 15:33 ET EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM
cancer (SCLC). J Cancer. 2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Listen mit klinischen Studien zu Tarlatamab. US National Library of Medicine. Abgerufen im
More news about: Amgen
Jun 03, 2026, 15:16 ET LA COMMISSION EUROPÉENNE APPROUVE IMDYLLTRA® D'AMGEN POUR LE TRAITEMENT DU CANCER DU POUMON À PETITES CELLULES DE STADE ÉTENDU
cancer (SCLC). J Cancer. 2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Liste des essais cliniques sur le tarlatamab. Bibliothèque nationale de médecine des États-Unis.
More news about: Amgen